Ironwood Pharmaceuticals, Inc. has a 12 month low of $9.73 and a 12 month high of $12.66.

Source: https://www.etfdailynews.com/2023/05/18/envestnet-asset-management-inc-has-2-78-million-stock-holdings-in-ironwood-pharmaceuticals-inc-nasdaqirwd/

Piper Sandler upped their price objective on shares of Ironwood Pharmaceuticals from $16.00 to $19.00 in a report on Tuesday, May 23rd.

Source: https://www.etfdailynews.com/2023/05/28/first-trust-advisors-lp-has-4-92-million-stake-in-ironwood-pharmaceuticals-inc-nasdaqirwd/

PNC Financial Services Group Inc. increased its stake in shares of Ironwood Pharmaceuticals by 41.4% during the 2nd quarter.

Source: https://www.americanbankingnews.com/2023/12/30/sg-americas-securities-llc-purchases-shares-of-188807-ironwood-pharmaceuticals-inc-nasdaqirwd.html

TheStreet lowered Ironwood Pharmaceuticals from a “b-” rating to a “d-” rating in a research report on Tuesday, August 8th.

Source: https://www.dailypolitical.com/2023/09/20/foundry-partners-llc-has-5-13-million-stake-in-ironwood-pharmaceuticals-inc-nasdaqirwd.html